Central nervous system tumours in adolescents

European Journal of Cancer

Volumn 39, Issue 18, 2003, Pages 2643-2650

  Capra, M ^a   Hargrave, D ^b   Bartels, U ^a   Hyder, D ^a   Huang, A ^a   Bouffet, E ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Adolescents; Brain tumours; Multidisciplinary management; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LOMUSTINE; SOMATOSTATIN DERIVATIVE; VINCRISTINE;

ADOLESCENT; ASTROCYTOMA; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CRANIOPHARYNGIOMA; DATA ANALYSIS; EPENDYMOMA; GERM CELL TUMOR; GLIOMA; HIGH GRADE GLIOMA; HUMAN; MEDULLOBLASTOMA; PATIENT CARE; PEDIATRICS; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0344983460     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.09.003     Document Type: Article

References (38)

1. Gurney J.G., Smith M.A., Bunin G.R. CNS and miscellaneous intracranial and intraspinal neoplasms. Ries L.A., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L.et al. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. NIH Pub. No. 99-4649. 1999;46-60 National Cancer Institute, Bethesda.
2. Tait D.M., Thornton-Jones H., Bloom H.J., Lemerle J., Morris-Jones P. Adjuvant chemotherapy for medulloblastoma. the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I) Eur. J. Cancer. 26:1990;464-469.
3. Bailey C.C., Gnekow A., Wellek S.et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO). SIOP II Med. Pediatr. Oncol. 25:1995;166-178.
4. Taylor R.E., Bailey C.C., Robinson K.et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma. The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study J. Clin. Oncol. 21:2003;1581-1591.
5. Stiller C. Epidemiology of cancer in adolescents. Med. Pediatr. Oncol. 39:2002;149-155.
6. Smith M.A., Gurney J.G., Gloeckler Ries L.A. Cancer among adolescents 15-19 years old. Ries L.A., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L.et al. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. NIH Pub. No. 99-4649. 1999;157-164 National Cancer Institute, Bethesda.
7. CBTRUS (2002) Statistical Report: Primary Brain Tumors in the United States, 1995-1999. Central Brain Tumor Registry of the United States, 2003.
8. Shochat S.J., Fremgen A.M., Murphy S.B.et al. Childhood cancer. patterns of protocol participation in a national survey CA Cancer J. Clin. 51:2001;119-130.
9. Cancer Statistics: Registrations. Registrations of Cancer Diagnosed in 1995-1997, England. 2001;Stationery Office, London.
10. Zeltzer P.M., Boyett J.M., Finlay J.L.et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children. conclusions from the Children's Cancer Group 921 randomized phase III study J. Clin. Oncol. 17:1999;832-845.
11. Pollack I.F., Gerszten P.C., Martinez A.J.et al. Intracranial ependymomas of childhood. long-term outcome and prognostic factors Neurosurgery. 37:1995;655-666.
12. Wisoff J.H., Boyett J.M., Berger M.S.et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood. a report of the Children's Cancer Group trial no. CCG-945 J. Neurosurg. 89:1998;52-59.
13. Albright A.L., Sposto R., Holmes E.et al. Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors. Neurosurgery. 47:2000;879-885.
14. Kortmann R.D., Kuhl J., Timmermann B.et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood. results of the German prospective randomized trial HIT '91 Int. J. Radiat. Oncol. Biol. Phys. 46:2000;269-279.
15. Gentet J.C., Bouffet E., Doz F.et al. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma. results of the M7 French Cooperative Study J. Neurosurg . 82:1995;608-614.
16. Evans A.E., Jenkin R.D., Sposto R.et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J. Neurosurg. 72:1990;572-582.
17. Mulhern R.K., Kepner J.L., Thomas P.R., Armstrong F.D., Friedman H.S., Kun L.E. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation. a Pediatric Oncology Group study J. Clin. Oncol. 16:1998;1723-1728.
18. Carrie C., Lasset C., Alapetite C.et al. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. Cancer. 74:1994;2352-2360.
19. Greenberg H.S., Chamberlain M.C., Glantz M.J., Wang S. Adult medulloblastoma. multiagent chemotherapy Neuro-oncology. 3:2001;29-34.
20. Packer R.J., Goldwein J., Nicholson H.S.et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy. a Children's Cancer Group Study J. Clin. Oncol. 17:1999;2127-2136.
21. Carrie C., Hoffstetter S., Gomez F.et al. Impact of targeting deviations on outcome in medulloblastoma. study of the French Society of Pediatric Oncology (SFOP) Int. J. Radiat. Oncol. Biol. Phys. 45:1999;435-439.
22. Moody A.M., Norman A.R., Tait D. Paediatric tumours in the adult population. the experience of the Royal Marsden Hospital 1974-1990 Med. Pediatr. Oncol. 26:1996;153-159.
23. Carrie C., Lasset C., Blay J.Y.et al. Medulloblastoma in adults. survival and prognostic factors Radiother. Oncol. 29:1993;301-307.
24. Dhodapkar K., Dunkel I.J., Gardner S., Sapp M., Thoron L., Finlay J. Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors. Med. Pediatr. Oncol. 38:2002;47-48.
25. Finlay J.L., Boyett J.M., Yates A.J.et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J. Clin. Oncol. 13:1995;112-123.
26. Pollack I.F., Finkelstein S.D., Burnham J.et al. Age and TP53 mutation frequency in childhood malignant gliomas. results in a multi-institutional cohort Cancer Res. 61:2001;7404-7407.
27. Pollack I.F., Finkelstein S.D., Woods J.et al. Expression of p53 and prognosis in children with malignant gliomas. N. Engl. J. Med. 346:2002;420-427.
28. Cunningham J.M., Kimmel D.W., Scheithauer B.W., O'Fallon J.R., Novotny P.J., Jenkins R.B. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin. relationships and prognostic value J. Neurosurg. 86:1997;121-130.
29. Bamberg M., Kortmann R.D., Calaminus G.et al. Radiation therapy for intracranial germinoma. results of the German cooperative prospective trials MAKEI 83/86/89 J. Clin. Oncol. 17:1999;2585-2592.
30. Bouffet E., Baranzelli M.C., Patte C.et al. Combined treatment modality for intracranial germinomas. results of a multicentre SFOP experience. Societe Francaise d'Oncologie Pediatrique Br. J. Cancer. 79:1999;1199-1204.
31. Calaminus G., Andreussi L., Garre M.L., Kortmann R.D., Schober R., Gobel U. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT). Klin. Padiatr. 209:1997;222-227.
32. Calaminus G., Nicholson J.C., Alapetite C.et al. Malignant CNS germ cell tumors (GCTS). interim analysis after 5 years of SIOP CNS GCT 96 Med. Pediatr. Oncol. 39:2002;227.
33. Merchant T.E., Kiehna E.N., Miles M.A., Zhu J., Xiong X., Mulhern R.K. Acute effects of irradiation on cognition. changes in attention on a computerized continuous performance test during radiotherapy in pediatric patients with localized primary brain tumors Int. J. Radiat. Oncol. Biol. Phys. 53:2002;1271-1278.
34. Lafferty A.R., Chrousos G.P. Pituitary tumors in children and adolescents. J. Clin. Endocrinol. Metab. 84:1999;4317-4323.
35. Rebounders Canada: a non-profit organization that offers support to and networking to adult survivors of childhood cancer and their families: www.rebounders.org , 2003.
36. On The Tips of The Toes: an organisation promoting outdoor wildlife expeditions and other nature oriented experiences for children and adolescents with cancer, 2003. http://www.cbtrus.org/2002/2002report.pdf.
37. Hargrave D.R., Bouffet E. Quality of health information on the internet in paediatric neur-oncology websites. Med. Pediatr. Oncol. 39(4):2002;298.
38. Sister Frances Dominica. Douglas House: A 'respice' for young people. Eur J Cancer 2003, this issue (doi: 10.1016/j.ejca.2003.08.003).